Car T Cell Therapy clinical trials

Explore recruiting car t cell therapy clinical trials.

Recruiting car t cell therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Car T Cell Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Double-T - Improving outcomes in high-risk 2nd line relapsed/refractory Large B-Cell Lymphoma patients eligible for CAR-T-cell therapy with a Glofitamab-based induction and consolidation concept

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-CellTherapy

Sweden, France, Finland, Netherlands, Austria, Norway +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Temporal characterization of Extracellular Vesicles during cellular therapy using CAR-T cells and during the occurrence of Immune effector Cell-Associated Neurotoxicity Syndrome : the VESICANS study

France

Therapeutic use (Phase IV) EU CTIS Study details

Long-Term Follow-up of Patients Treated with Miltenyi Cell and Gene Therapies

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Programmed death ligand 1 (PD-L1) PET imaging in patients with (Diffuse) Large B-cell Lymphoma who are treated with CD19-directed CAR T-cell therapy: a pilot study

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Car T Cell Therapy trials by city

Car T Cell Therapy in Toronto Car T Cell Therapy in Vancouver Car T Cell Therapy in Montreal Car T Cell Therapy in Calgary Car T Cell Therapy in Edmonton Car T Cell Therapy in Ottawa Car T Cell Therapy in Winnipeg Car T Cell Therapy in Quebec City Car T Cell Therapy in Hamilton Car T Cell Therapy in Kitchener Car T Cell Therapy in London Car T Cell Therapy in Halifax Car T Cell Therapy in New York Car T Cell Therapy in Los Angeles Car T Cell Therapy in Chicago Car T Cell Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease